14-Sep-2026
Temporal Raises $550 Million in Series E Round: NYSE Content Update
PRNewswire (Mon, 14-Sep 9:05 AM ET)
Globe Newswire (Mon, 14-Sep 8:03 AM ET)
Teva Pharmaceutical Announces Major Senior Notes Financing
TipRanks (Fri, 11-Sep 4:33 PM ET)
Teva prices $4.9B senior notes to refinance higher-cost debt
Seeking Alpha News (Thu, 10-Sep 6:48 AM ET)
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
Globe Newswire (Thu, 10-Sep 6:04 AM ET)
Teva Announces Launch of Offering of Senior Notes
Globe Newswire (Mon, 7-Sep 3:53 AM ET)
Globe Newswire (Fri, 4-Sep 11:30 AM ET)
Globe Newswire (Wed, 2-Sep 7:03 AM ET)
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
Globe Newswire (Tue, 1-Sep 4:30 PM ET)
Globe Newswire (Mon, 31-Aug 4:06 PM ET)
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Teva Pharmaceutical Industries trades on the NYSE stock market under the symbol TEVA.
As of September 14, 2026, TEVA stock price climbed to $38.72 with 2,922,549 million shares trading.
TEVA has a beta of 0.88, meaning it tends to be less sensitive to market movements. TEVA has a correlation of 0.07 to the broad based SPY ETF.
TEVA has a market cap of $45.09 billion. This is considered a Large Cap stock.
Last quarter Teva Pharmaceutical Industries reported $4 billion in Revenue and $.02 earnings per share. This beat revenue expectation by $74 million and missed earnings estimates by -$.39.
In the last 3 years, TEVA traded as high as $39.22 and as low as $8.06.
The top ETF exchange traded funds that TEVA belongs to (by Net Assets): IEFA, EFA, EIS, EFG, WCMI.
TEVA has outperformed the market in the last year with a price return of +94.3% while the SPY ETF gained +16.9%. TEVA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.8% and +7.4%, respectively, while the SPY returned +2.8% and -0.8%, respectively.
TEVA support price is $36.31 and resistance is $37.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TEVA shares will trade within this expected range on the day.
